Markaki Anastasia, Grammatikopoulou Maria G, Venihaki Maria, Kyriazis John, Perakis Kostas, Stylianou Kostas
Department of Nutrition & Dietetics, Technological Educational Institute of Crete, Sitia, Greece.
Department of Nutrition & Dietetics, Alexander Technological Educational Institute, Thessaloniki, Greece.
Endocrinol Nutr. 2016 Nov;63(9):449-457. doi: 10.1016/j.endonu.2016.07.003.
The aim of the study was to examine the prevalence of protein-energy wasting (PEW) in hemodialysis (HD) and peritoneal dialysis (PD) patients in our center and determine whether adiponectin and leptin are involved in the development of PEW.
Prospective (18 months).
University Hospital of Heraklion, Crete, Greece.
Seventy-four end-stage-renal-disease patients, 47 on HD and 27 on PD.
At three sequential time points (baseline, 6 and 18 months) anthropometric, nutritional and inflammatory status data were collected. Serum adiponectin and leptin were also assessed at each time point. Patients were allocated to 3 strata according to PEW severity (0, 1-2 and ≥3 criteria for PEW).
Adiponectin and leptin levels were greater among PD compared to HD patients (p≤0.035). Adiponectin levels were incrementally greater across increasing strata of PEW (p≤0.002). Leptin showed the opposite trend, with lower levels in malnourished patients and higher levels in patients with zero PEW criteria (p≤0.042). Alterations of adiponectin levels during the observation period were dependent on PEW stratum (p≤0.021) and mode of dialysis (p≤0.002), after adjustment for age, dialysis vintage, gender and fat mass index. Particularly, adiponectin levels increased over time in HD patients with ≥3 criteria for PEW, whereas adiponectin levels decreased in PD patients with ≥3 criteria for PEW throughout the study. Leptin alterations over time were not affected by dialysis mode or PEW stratification.
Our study provides evidence that increased adiponectin and decreased leptin levels are independently associated with PEW and thus, poor prognosis.
本研究旨在调查我院中心血液透析(HD)和腹膜透析(PD)患者中蛋白质能量消耗(PEW)的患病率,并确定脂联素和瘦素是否参与PEW的发生发展。
前瞻性研究(18个月)。
希腊克里特岛伊拉克利翁大学医院。
74例终末期肾病患者,47例接受HD治疗,27例接受PD治疗。
在三个连续时间点(基线、6个月和18个月)收集人体测量、营养和炎症状态数据。每个时间点还评估血清脂联素和瘦素水平。根据PEW严重程度(PEW的0、1 - 2和≥3条标准)将患者分为3个分层。
与HD患者相比,PD患者的脂联素和瘦素水平更高(p≤0.035)。随着PEW分层增加,脂联素水平逐渐升高(p≤0.002)。瘦素呈现相反趋势,营养不良患者中水平较低,PEW标准为零的患者中水平较高(p≤0.042)。在调整年龄、透析龄、性别和脂肪质量指数后,观察期内脂联素水平的变化取决于PEW分层(p≤0.021)和透析方式(p≤0.002)。特别是,在整个研究中,符合≥3条PEW标准的HD患者脂联素水平随时间升高,而符合≥3条PEW标准的PD患者脂联素水平下降。瘦素随时间的变化不受透析方式或PEW分层的影响。
我们的研究提供了证据,表明脂联素升高和瘦素水平降低与PEW独立相关,因此与不良预后相关。